HIF-1α and BMAL1 in bone regeneration: crosstalk between hypoxia response and circadian rhythm

Abstract

Bone regeneration is initiated after a bone injury, such as a bone fracture or tooth extraction. It is a highly complex biological process involving multiple cell types, signaling molecules, and molecular pathways. The hypoxic microenvironment in the early stage of bone regeneration poses challenges to cell status and the final outcome of bone regeneration. During this phase, two key regulators—HIF-1α (the critical mediator of hypoxia response) and BMAL1 (the central component of the circadian rhythm)—orchestrate the activities of bone-regenerating cells, ensuring proper cellular function and orderly progression of bone repair. Existing studies have shown that there is a close crosstalk between HIF-1α and BMAL1, including regulation of gene expression, protein interaction, and regulation of downstream pathways. In this review, we discuss the respective regulatory roles of HIF-1α and BMAL1 in bone regeneration and further summarize their interactions within cells. Additionally, we extend the discussion to their interactions in other bone-related diseases, and summarize the existing research directions and deficiencies, providing new insights for in-depth studies of the hypoxia response and circadian rhythm systems.

References

[1] Datta HKet al.. The cell biology of bone metabolism. J. Clin. Pathol, 2008, 61: 577-587

[2] Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat. Rev. Rheumatol., 2015, 11: 45-54

[3] Araújo MG, Silva CO, Misawa M, Sukekava F. Alveolar socket healing: what can we learn?. Periodontology, 2015, 2000(68): 122-134

[4] Majidinia M, Sadeghpour A, Yousefi B. The roles of signaling pathways in bone repair and regeneration. J. Cell. Physiol., 2018, 233: 2937-2948

[5] Schlundt Cet al.. Macrophages in bone fracture healing: their essential role in endochondral ossification. Bone, 2018, 106: 78-89

[6] Pajarinen Jet al.. Mesenchymal stem cell-macrophage crosstalk and bone healing. Biomaterials, 2019, 196: 80-89

[7] Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future directions. BMC Med., 2011, 9 66

[8] Maruyama Met al.. Modulation of the Inflammatory Response and Bone Healing. Front Endocrinol. (Lausanne), 2020, 11: 386

[9] Duda GNet al.. The decisive early phase of bone regeneration. Nat. Rev. Rheumatol., 2023, 19: 78-95

[10] Gaber Tet al.. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!. Ann. Rheum. Dis., 2005, 64: 971-980

[11] Lang Aet al.. MIF does only marginally enhance the pro-regenerative capacities of DFO in a mouse-osteotomy-model of compromised bone healing conditions. Bone, 2022, 154: 116247

[12] Loeffler J, Duda GN, Sass FA, Dienelt A. The metabolic microenvironment steers bone tissue regeneration. Trends Endocrinol. Metab., 2018, 29: 99-110

[13] Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat. Rev. Rheumatol., 2012, 8: 133-143

[14] Mangiavini Let al.. Loss of VHL in mesenchymal progenitors of the limb bud alters multiple steps of endochondral bone development. Dev. Biol., 2014, 393: 124-136

[15] Carmeliet P. Angiogenesis in health and disease. Nat. Med., 2003, 9: 653-660

[16] Jaakkola Pet al.. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 2001, 292: 468-472

[17] Maxwell PHet al.. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 1999, 399: 271-275

[18] Ohh Met al.. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol., 2000, 2: 423-427

[19] Campochiaro PA. Ocular neovascularization. J. Mol. Med., 2013, 91: 311-321

[20] Park SYet al.. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J. Pineal Res., 2010, 48: 178-184

[21] Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol., 2001, 13: 167-171

[22] Wu YCet al.. Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity. PLoS One, 2015, 10: e0126750

[23] Tao Jet al.. Spatiotemporal correlation between HIF-1α and bone regeneration. FASEB J, 2022, 36: e22520

[24] Mohawk JA, Green CB, Takahashi JS. Central and peripheral circadian clocks in mammals. Annu. Rev. Neurosci., 2012, 35: 445-462

[25] Ripperger JA, Schibler U. Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat. Genet., 2006, 38: 369-374

[26] Yoshitane Het al.. CLOCK-controlled polyphonic regulation of circadian rhythms through canonical and noncanonical E-boxes. Mol. Cell. Biol., 2014, 34: 1776-1787

[27] Bunger MKet al.. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell, 2000, 103: 1009-1017

[28] Yu Set al.. Circadian rhythm modulates endochondral bone formation via MTR1/AMPKβ1/BMAL1 signaling axis. Cell Death Differ, 2022, 29: 874-887

[29] Kikyo N. Circadian regulation of bone remodeling. Int. J. Mol. Sci., 2024, 25: 4717

[30] Luo Bet al.. Circadian rhythms affect bone reconstruction by regulating bone energy metabolism. J. Transl. Med., 2021, 19 410

[31] Wu QYet al.. Emerging role of circadian rhythm in bone remodeling. J. Mol. Med., 2019, 97: 19-24

[32] Nie T, Nepovimova E, Wu Q. Circadian rhythm, hypoxia, and cellular senescence: From molecular mechanisms to targeted strategies. Eur. J. Pharmacol., 2025, 990: 177290

[33] Li Yet al.. Circadian clock gene clock is involved in the pathogenesis of preeclampsia through hypoxia. Life Sci., 2020, 247: 117441

[34] Tian Let al.. Ceramide-1-phosphate alleviates high-altitude pulmonary edema by stabilizing circadian ARNTL-mediated mitochondrial dynamics. J. Adv. Res., 2024, 60: 75-92

[35] Ghorbel MT, Coulson JM, Murphy D. Cross-talk between hypoxic and circadian pathways: cooperative roles for hypoxia-inducible factor 1α and CLOCK in transcriptional activation of the vasopressin gene. Mol. Cell. Neurosci., 2003, 22: 396-404

[36] Wang Fet al.. BMAL1 may be involved in angiogenesis and peritumoral cerebral edema of human glioma by regulating VEGF and ANG2. Aging, 2021, 13: 24675-24685

[37] Huang Net al.. Crystal structure of the heterodimeric CLOCK:BMAL1 transcriptional activator complex. Science, 2012, 337: 189-194

[38] Wu Det al.. Structural integration in hypoxia-inducible factors. Nature, 2015, 524: 303-308

[39] Bersten DC, Sullivan AE, Peet DJ, Whitelaw ML. bHLH-PAS proteins in cancer. Nat. Rev. Cancer, 2013, 13: 827-841

[40] Hogenesch JB, Gu YZ, Jain S, Bradfield CA. The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc. Natl. Acad. Sci. USA, 1998, 95: 5474-5479

[41] Takahata Set al.. Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock. Biochem. Biophys. Res. Commun., 1998, 248: 789-794

[42] Teh SWet al.. Hypoxia in bone and oxygen releasing biomaterials in fracture treatments using mesenchymal stem cell therapy: a review. Front. Cell Dev. Biol., 2021, 9: 634131

[43] Walters G, Pountos I, Giannoudis PV. The cytokines and micro-environment of fracture haematoma: Current evidence. J. Tissue Eng. Regen. Med., 2018, 12: e1662-e1677

[44] Harrison JS, Rameshwar P, Chang V, Bandari P. Oxygen saturation in the bone marrow of healthy volunteers. Blood, 2002, 99: 394-394

[45] Yellowley CE, Genetos DC. Hypoxia signaling in the skeleton: implications for bone health. Curr. Osteoporos. Rep., 2019, 17: 26-35

[46] Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol., 2013, 13: 159-175

[47] Cai Bet al.. N2-polarized neutrophils guide bone mesenchymal stem cell recruitment and initiate bone regeneration: a missing piece of the bone regeneration puzzle. Adv. Sci., 2021, 8: e2100584

[48] Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat. Rev. Drug Discov., 2016, 15: 551-567

[49] Ghiasi MSet al.. Bone fracture healing in mechanobiological modeling: a review of principles and methods. Bone Rep., 2017, 6: 87-100

[50] Hankenson KD, Gagne K, Shaughnessy M. Extracellular signaling molecules to promote fracture healing and bone regeneration. Adv. Drug Deliv. Rev., 2015, 94: 3-12

[51] Camal Ruggieri IN, Cícero AM, Issa JPM, Feldman S. Bone fracture healing: perspectives according to molecular basis. J. Bone Min. Miner., 2021, 39: 311-331

[52] Kenkre JS, Bassett J. The bone remodelling cycle. Ann. Clin. Biochem., 2018, 55: 308-327

[53] Trombelli Let al.. Modeling and remodeling of human extraction sockets. J. Clin. Periodontol., 2008, 35: 630-639

[54] Łuczak JWet al.. The future of bone repair: emerging technologies and biomaterials in bone regeneration. Int. J. Mol. Sci., 2024, 25: 12766

[55] Reinke Set al.. Terminally differentiated CD8⁺ T cells negatively affect bone regeneration in humans. Sci. Transl. Med., 2013, 5: 177ra36

[56] Wu Cet al.. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. Genes Dev., 2015, 29: 817-831

[57] Sun Het al.. Bone microenvironment regulative hydrogels with ROS scavenging and prolonged oxygen-generating for enhancing bone repair. Bioact. Mater., 2023, 24: 477-496

[58] Lu Fet al.. Is there a role for N1-N2 neutrophil phenotypes in bone regeneration? A systematic review. Bone, 2024, 181: 117021

[59] Herath TDKet al.. In vivo efficacy of neutrophil-mediated bone regeneration using a rabbit calvarial defect model. Int. J. Mol. Sci., 2021, 22: 13016

[60] Bastian OWet al.. Neutrophils inhibit synthesis of mineralized extracellular matrix by human bone marrow-derived stromal cells in vitro. Front. Immunol., 2018, 9: 945

[61] Meesters DMet al.. Deficiency of inducible and endothelial nitric oxide synthase results in diminished bone formation and delayed union and nonunion development. Bone, 2016, 83: 111-118

[62] Dishowitz MIet al.. Systemic inhibition of canonical Notch signaling results in sustained callus inflammation and alters multiple phases of fracture healing. PLoS One, 2013, 8: e68726

[63] Linnemann C, Nussler AK, Histing T, Ehnert S. Febrile-range hyperthermia can prevent toxic effects of neutrophil extracellular traps on mesenchymal stem cells. Int. J. Mol. Sci., 2022, 23: 16208

[64] Walmsley SR, McGovern NN, Whyte MK, Chilvers ER. The HIF/VHL pathway: from oxygen sensing to innate immunity. Am. J. Respir. Cell Mol. Biol., 2008, 38: 251-255

[65] Cassatella MA, Östberg NK, Tamassia N, Soehnlein O. Biological roles of neutrophil-derived granule proteins and cytokines. Trends Immunol., 2019, 40: 648-664

[66] Hoenderdos Ket al.. Hypoxia upregulates neutrophil degranulation and potential for tissue injury. Thorax, 2016, 71: 1030-1038

[67] Ong CWMet al.. Hypoxia increases neutrophil-driven matrix destruction after exposure to Mycobacterium tuberculosis. Sci. Rep., 2018, 8 11475

[68] McGovern NNet al.. Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils. J. Immunol., 2011, 186: 453-463

[69] Walmsley SRet al.. Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity. J. Exp. Med., 2005, 201: 105-115

[70] Wu AC, Raggatt LJ, Alexander KA, Pettit AR. Unraveling macrophage contributions to bone repair. Bonekey Rep., 2013, 2: 373

[71] Wang Set al.. Metabolic reprogramming of macrophages during infections and cancer. Cancer Lett., 2019, 452: 14-22

[72] Hu J, Liu X, Tang Y. HMGB1/Foxp1 regulates hypoxia-induced inflammatory response in macrophages. Cell Biol. Int., 2022, 46: 265-277

[73] Rius Jet al.. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature, 2008, 453: 807-811

[74] Ivashkiv LB. The hypoxia-lactate axis tempers inflammation. Nat. Rev. Immunol., 2020, 20: 85-86

[75] Karshovska Eet al.. HIF-1α (hypoxia-inducible factor-1α) promotes macrophage necroptosis by regulating miR-210 and miR-383. Arterioscler Thromb. Vasc. Biol., 2020, 40: 583-596

[76] Scheerer Net al.. Myeloid hypoxia-inducible factor-1α is essential for skeletal muscle regeneration in mice. J. Immunol., 2013, 191: 407-414

[77] Trimm E, Red-Horse K. Vascular endothelial cell development and diversity. Nat. Rev. Cardiol., 2023, 20: 197-210

[78] Nguyen VTet al.. Effect of chemically induced hypoxia on osteogenic and angiogenic differentiation of bone marrow mesenchymal stem cells and human umbilical vein endothelial cells in direct coculture. Cells, 2020, 9: 757

[79] Ahluwalia A, Tarnawski S. A. Critical role of hypoxia sensor-HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr. Med. Chem., 2012, 19: 90-97

[80] Hoeben Aet al.. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev., 2004, 56: 549-580

[81] Tang Net al.. Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell, 2004, 6: 485-495

[82] Lin Det al.. Hypoxia-induced reprogramming of glucose-dependent metabolic pathways maintains the stemness of human bone marrow-derived endothelial progenitor cells. Sci. Rep., 2023, 13 8776

[83] He Qet al.. Enhancement of de novo lipogenesis by the IDH1 and IDH2-dependent reverse TCA cycle maintains the growth and angiogenic capacity of bone marrow-derived endothelial progenitor cells under hypoxia. Free Radic. Biol. Med., 2024, 213: 327-342

[84] Huang Yet al.. Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function. Proc. Natl. Acad. Sci. USA, 2012, 109: 17478-17483

[85] Dos Santos Fet al.. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J. Cell. Physiol, 2010, 223: 27-35

[86] Kwon SYet al.. Hypoxia enhances cell properties of human mesenchymal stem cells. Tissue Eng. Regen. Med., 2017, 14: 595-604

[87] Pattappa Get al.. Continuous and uninterrupted oxygen tension influences the colony formation and oxidative metabolism of human mesenchymal stem cells. Tissue Eng. Part C. Methods, 2013, 19: 68-79

[88] Weijers EMet al.. The influence of hypoxia and fibrinogen variants on the expansion and differentiation of adipose tissue-derived mesenchymal stem cells. Tissue Eng. Part A, 2011, 17: 2675-2685

[89] Utting JCet al.. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp. Cell Res., 2006, 312: 1693-1702

[90] Antebi Bet al.. Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells. Stem Cell Res. Ther., 2018, 9: 265

[91] Yang Met al.. Hypoxia reduces the osteogenic differentiation of peripheral blood mesenchymal stem cells by upregulating Notch-1 expression. Connect. Tissue Res., 2019, 60: 583-596

[92] Zhang Pet al.. Hypoxia suppresses osteogenesis of bone mesenchymal stem cells via the extracellular signal regulated 1/2 and p38 mitogen activated protein kinase signaling pathways. Mol. Med. Rep., 2017, 16: 5515-5522

[93] Komori T. Regulation of osteoblast differentiation by Runx2. Adv. Exp. Med. Biol., 2010, 658: 43-49

[94] Hong CYet al.. Metformin reduces bone resorption in apical periodontitis through regulation of osteoblast and osteoclast differentiation. J. Endod., 2023, 49: 1129-1137

[95] Li Jet al.. Targeting endogenous hydrogen peroxide at bone defects promotes bone repair. Adv. Funct. Mater., 2022, 32: 2111208

[96] Lee DH, Lim BS, Lee YK, Yang HC. Effects of hydrogen peroxide (H2O2) on alkaline phosphatase activity and matrix mineralization of odontoblast and osteoblast cell lines. Cell Biol. Toxicol., 2006, 22: 39-46

[97] Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med., 2001, 31: 509-519

[98] Okamoto Tet al.. Phosphate enhances reactive oxygen species production and suppresses osteoblastic differentiation. J. Bone Miner. Metab., 2014, 32: 393-399

[99] Chen C, Yan S, Geng ZD, Wang Z. Fracture repair by IOX2: regulation of the hypoxia inducible factor-1α signaling pathway and BMSCs. Eur. J. Pharmacol., 2022, 921: 174864

[100] Chen Cet al.. HIF/Ca2+/NO/ROS is critical in roxadustat treating bone fracture by stimulating the proliferation and migration of BMSCs. Life Sci., 2021, 264: 118684

[101] Zou Det al.. Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1α mediated BMSCs. Biomaterials, 2012, 33: 2097-2108

[102] Zou Det al.. In vitro study of enhanced osteogenesis induced by HIF-1α-transduced bone marrow stem cells. Cell Prolif., 2011, 44: 234-243

[103] Zou Wet al.. Hypoxia enhances glucocorticoid-induced apoptosis and cell cycle arrest via the PI3K/Akt signaling pathway in osteoblastic cells. J. Bone Miner. Metab., 2015, 33: 615-624

[104] Zhang Wet al.. MicroRNA-18a regulates the pyroptosis, apoptosis, and necroptosis (PANoptosis) of osteoblasts induced by tumor necrosis factor-α via hypoxia-inducible factor-1α. Int. Immunopharmacol., 2024, 128: 111453

[105] Wang Get al.. Short-term hypoxia accelerates bone loss in ovariectomized rats by suppressing osteoblastogenesis but enhancing osteoclastogenesis. Med. Sci. Monit., 2016, 22: 2962-2971

[106] Kok SHet al.. Sirtuin 6 modulates hypoxia-induced apoptosis in osteoblasts via inhibition of glycolysis: implication for pathogenesis of periapical lesions. J. Endod., 2015, 41: 1631-1637

[107] Lai EHet al.. Metformin ameliorates periapical lesions through suppression of hypoxia-induced apoptosis of osteoblasts. J. Endod., 2018, 44: 1817-1825

[108] Li Set al.. Metallothionein 3 promotes osteoblast differentiation in C2C12 cells via reduction of oxidative stress. Int. J. Mol. Sci., 2021, 22: 4312

[109] Zhang Let al.. Chronic intermittent hypobaric hypoxia enhances bone fracture healing. Front. Endocrinol., 2020, 11: 582670

[110] Peng Y, Wu S, Li Y, Crane JL. Type H blood vessels in bone modeling and remodeling. Theranostics, 2020, 10: 426-436

[111] Qiao J, Liu A, Sun C, Liu Q. HIF1A overexpression promotes osteoblast differentiation through activation of autophagy to alleviate osteoporosis. Sci. Rep., 2025, 15 30370

[112] Chen Cet al.. Activation of BMP4/SMAD pathway by HIF-1α in hypoxic environment promotes osteogenic differentiation of BMSCs and leads to ectopic bone formation. Tissue Cell, 2024, 88: 102376

[113] Wan Cet al.. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc. Natl. Acad. Sci. USA, 2008, 105: 686-691

[114] Orriss IRet al.. Hypoxia stimulates vesicular ATP release from rat osteoblasts. J. Cell. Physiol., 2009, 220: 155-162

[115] Arnett TRet al.. Hypoxia is a major stimulator of osteoclast formation and bone resorption. J. Cell. Physiol., 2003, 196: 2-8

[116] Lemma Set al.. Energy metabolism in osteoclast formation and activity. Int. J. Biochem. Cell Biol., 2016, 79: 168-180

[117] Indo Yet al.. Metabolic regulation of osteoclast differentiation and function. J. Bone Min. Res., 2013, 28: 2392-2399

[118] Nakazawa MS, Keith B, Simon MC. Oxygen availability and metabolic adaptations. Nat. Rev. Cancer, 2016, 16: 663-673

[119] Morten KJ, Badder L, Knowles HJ. Differential regulation of HIF-mediated pathways increases mitochondrial metabolism and ATP production in hypoxic osteoclasts. J. Pathol., 2013, 229: 755-764

[120] Hulley PAet al.. Hypoxia-inducible factor 1-alpha does not regulate osteoclastogenesis but enhances bone resorption activity via prolyl-4-hydroxylase 2. J. Pathol., 2017, 242: 322-333

[121] Kang Het al.. Osteoblast hypoxia-inducible factor-1α pathway activation restrains osteoclastogenesis via the interleukin-33-microRNA-34a-Notch1 pathway. Front. Immunol., 2017, 8: 1312

[122] Knowles HJ. The adenosine A2B receptor drives osteoclast-mediated bone resorption in hypoxic microenvironments. Cells, 2019, 8: 624

[123] Tang Yet al.. HIF-1α mediates osteoclast-induced mandibular condyle growth via AMPK. signaling. J. Dent. Res., 2020, 99: 1377-1386

[124] Tian Yet al.. HIF-1α regulates osteoclast activation and mediates osteogenesis during mandibular bone repair via CT-1. Oral. Dis., 2022, 28: 428-441

[125] Nakashima T, Takayanagi H. New regulation mechanisms of osteoclast differentiation. Ann. N. Y Acad. Sci., 2011, 1240: E13-E18

[126] Wang N, Hao Y, Fu L. Trimethylamine-N-oxide promotes osteoclast differentiation and bone loss via activating ROS-dependent NF-κB signaling pathway. Nutrients, 2022, 14: 3955

[127] Scheiermann Cet al.. Adrenergic nerves govern circadian leukocyte recruitment to tissues. Immunity, 2012, 37: 290-301

[128] Melchart Det al.. Circadian variation of the phagocytic activity of polymorphonuclear leukocytes and of various other parameters in 13 healthy male adults. Chronobiol. Int., 1992, 9: 35-45

[129] Hriscu ML. Modulatory factors of circadian phagocytic activity. Ann. N. Y. Acad. Sci., 2005, 1057: 403-430

[130] Casanova-Acebes Met al.. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell, 2013, 153: 1025-1035

[131] Rittner HLet al.. CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo. Brain Behav. Immun., 2007, 21: 1021-1032

[132] Adrover JMet al.. A neutrophil timer coordinates immune defense and vascular protection. Immunity, 2019, 50: 390-402.e10

[133] Gibbs Jet al.. An epithelial circadian clock controls pulmonary inflammation and glucocorticoid action. Nat. Med., 2014, 20: 919-926

[134] Ella K, Csépányi-Kömi R, Káldi K. Circadian regulation of human peripheral neutrophils. Brain Behav. Immun., 2016, 57: 209-221

[135] Geiger SS, Curtis AM, O’Neill LAJ, Siegel RM. Daily variation in macrophage phagocytosis is clock-independent and dispensable for cytokine production. Immunology, 2019, 157: 122-136

[136] Keller Met al.. A circadian clock in macrophages controls inflammatory immune responses. Proc. Natl. Acad. Sci. USA, 2009, 106: 21407-21412

[137] Oliva-Ramírez Jet al.. Crosstalk between circadian rhythmicity, mitochondrial dynamics and macrophage bactericidal activity. Immunology, 2014, 143: 490-497

[138] Lellupitiyage Don SSet al.. Macrophage circadian rhythms are differentially affected based on stimuli. Integr. Biol., 2022, 14: 62-75

[139] Zhou Yet al.. Bmal1 regulates macrophage polarize through glycolytic pathway in alcoholic liver disease. Front. Pharmacol., 2021, 12: 640521

[140] Hong Het al.. REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome. Biochem. Pharm., 2021, 192: 114701

[141] Tian Yet al.. Bmal1 knockout aggravates Porphyromonas gingivalis-induced periodontitis by activating the NF-κB pathway. J. Appl. Oral. Sci., 2025, 33: e20240388

[142] Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell, 2002, 10: 417-426

[143] O’Siorain JRet al.. Time-of-day control of mitochondria regulates NLRP3 inflammasome activation in macrophages. FASEB J., 2024, 38: e70235

[144] Astone Met al.. The circadian protein BMAL1 supports endothelial cell cycle during angiogenesis. Cardiovasc. Res., 2023, 119: 1952-1968

[145] Yin Yet al.. Endothelial BMAL1 decline during aging leads to bone loss by destabilizing extracellular fibrillin-1. J. Clin. Invest., 2024, 134: e176660

[146] Grafe Iet al.. TGF-β family signaling in mesenchymal differentiation. Cold Spring Harb. Perspect. Biol., 2018, 10: a022202

[147] Grafe Iet al.. Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta. Nat. Med., 2014, 20: 670-675

[148] Jensen LDet al.. Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish. Cell Rep., 2012, 2: 231-241

[149] Tsuzuki Ket al.. Adverse effect of circadian rhythm disorder on reparative angiogenesis in hind limb ischemia. J. Am. Heart Assoc., 2021, 10: e020896

[150] Xu Let al.. Bmal1 downregulation worsens critical limb ischemia by promoting inflammation and impairing angiogenesis. Front. Cardiovasc Med., 2021, 8: 712903

[151] Weger Met al.. Stem cells and the circadian clock. Dev. Biol., 2017, 431: 111-123

[152] He Y, Chen Y, Zhao Q, Tan Z. Roles of brain and muscle ARNT-like 1 and Wnt antagonist Dkk1 during osteogenesis of bone marrow stromal cells. Cell Prolif., 2013, 46: 644-653

[153] Zhang Het al.. Adipocytes derived from human bone marrow mesenchymal stem cells exert inhibitory effects on osteoblastogenesis. Curr. Mol. Med., 2011, 11: 489-502

[154] Lin Fet al.. Over-expression of circadian clock gene Bmal1 affects proliferation and the canonical Wnt pathway in NIH-3T3 cells. Cell Biochem. Funct., 2013, 31: 166-172

[155] Samsa WE, Vasanji A, Midura RJ, Kondratov RV. Deficiency of circadian clock protein BMAL1 in mice results in a low bone mass phenotype. Bone, 2016, 84: 194-203

[156] Guo Bet al.. The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway. FASEB J, 2012, 26: 3453-3463

[157] Sahar Set al.. Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PLoS One, 2010, 5: e8561

[158] Marcheva Bet al.. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature, 2010, 466: 627-631

[159] Sato Fet al.. Smad3 and Snail show circadian expression in human gingival fibroblasts, human mesenchymal stem cell, and in mouse liver. Biochem. Biophys. Res. Commun., 2012, 419: 441-446

[160] Chen Yet al.. Age-related BMAL1 change affects mouse bone marrow stromal cell proliferation and osteo-differentiation potential. Arch. Med. Sci., 2012, 8: 30-38

[161] Reale MEet al.. The transcription factor Runx2 is under circadian control in the suprachiasmatic nucleus and functions in the control of rhythmic behavior. PLoS One, 2013, 8: e54317

[162] Zhuo H, Wang Y, Zhao Q. The interaction between Bmal1 and Per2 in mouse BMSC osteogenic differentiation. Stem Cells Int., 2018, 2018: 3407821

[163] Fu Let al.. The molecular clock mediates leptin-regulated bone formation. Cell, 2005, 122: 803-815

[164] Hirai T, Tanaka K, Togari A. β-adrenergic receptor signaling regulates Ptgs2 by driving circadian gene expression in osteoblasts. J. Cell Sci., 2014, 127: 3711-3719

[165] Jouffe Cet al.. The circadian clock coordinates ribosome biogenesis. PLoS Biol, 2013, 11: e1001455

[166] Lipton, Jonathan, O. et al. The circadian protein BMAL1 regulates translation in response to S6K1-mediated phosphorylation. Cell 161, 1138–1151 (2015).

[167] Patel SA, Velingkaar NS, Kondratov RV. Transcriptional control of antioxidant defense by the circadian clock. Antioxid. Redox Signal, 2014, 20: 2997-3006

[168] Li Het al.. BMAL1 regulates osteoblast differentiation through mTOR/GSK3β/β-catenin pathway. J. Mol. Endocrinol., 2023, 70: e220181

[169] Xiaoguang L, Xiao-long G, Bin G. BMAL1 gene regulates the osteogenic differentiation of bone marrow mesenchymal stem cells. Hua Xi Kou Qiang Yi Xue Za Zhi, 2016, 34: 312-316

[170] Qian Zet al.. Postnatal conditional deletion of Bmal1 in osteoblasts enhances trabecular bone formation via increased BMP2 signals. J. Bone Miner. Res., 2020, 35: 1481-1493

[171] Takarada Tet al.. Bone resorption is regulated by circadian clock in osteoblasts. J. Bone Miner. Res., 2017, 32: 872-881

[172] Aoyama S, Shibata S. The role of circadian rhythms in muscular and osseous physiology and their regulation by nutrition and exercise. Front. Neurosci., 2017, 11: 63

[173] Xu Cet al.. Circadian clock regulates bone resorption in mice. J. Bone Miner. Res., 2016, 31: 1344-1355

[174] Zhou Xet al.. BMAL1 deficiency promotes skeletal mandibular hypoplasia via OPG downregulation. Cell Prolif., 2018, 51: e12470

[175] Li Xet al.. BMAL1 regulates balance of osteogenic-osteoclastic function of bone marrow mesenchymal stem cells in type 2 diabetes mellitus through the NF-κB pathway. Mol. Biol. Rep., 2018, 45: 1691-1704

[176] Liu M, Sun Y, Zhang Q. Emerging role of extracellular vesicles in bone remodeling. J. Dent. Res., 2018, 97: 859-868

[177] Zhou X, Cao H, Yuan Y, Wu W. Biochemical signals mediate the crosstalk between cartilage and bone in osteoarthritis. Biomed. Res. Int., 2020, 2020: 5720360

[178] Koritala BSCet al.. Intermittent hypoxia alters the circadian expression of clock genes in mouse brain and liver. Genes., 2021, 12: 1627

[179] Xie Tet al.. The relationship between HIF1α and clock gene expression in patients with obstructive sleep apnea. Nat. Sci. Sleep., 2022, 14: 381-392

[180] Gabryelska Aet al.. Disruption of circadian rhythm genes in obstructive sleep apnea patients—possible mechanisms involved and clinical implication. Int. J. Mol. Sci., 2022, 23: 709

[181] Swanson CMet al.. Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep. J. Bone Miner. Res., 2015, 30: 199-211

[182] Sadaf Set al.. Effect of obstructive sleep apnea on bone mineral density. Turk. Thorac. J, 2021, 22: 301-310

[183] Manella Get al.. Hypoxia induces a time- and tissue-specific response that elicits intertissue circadian clock misalignment. Proc. Natl. Acad. Sci. USA, 2020, 117: 779-786

[184] Dandavate Vet al.. Hepatic BMAL1 and HIF1α regulate a time-dependent hypoxic response and prevent hepatopulmonary-like syndrome. Cell Metab., 2024, 36: 2038-2053.e5

[185] Kim E-Jet al.. Transcriptional activation of HIF-1 by RORα and its role in hypoxia signaling. Arterioscler. Thromb. Vasc. Biol., 2008, 28: 1796-1802

[186] Diao Xet al.. Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex. Nat. Commun., 2025, 16 1282

[187] Michael AKet al.. Cooperation between bHLH transcription factors and histones for DNA access. Nature, 2023, 619: 385-393

[188] Xue Tet al.. Investigations of the CLOCK and BMAL1 proteins binding to DNA: a molecular dynamics simulation study. PLoS One, 2016, 11: e0155105

[189] Zhang Jet al.. Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer. Cell Mol. Biol. Lett., 2025, 30: 2

[190] Atchley WR, Fitch WM. A natural classification of the basic helix-loop-helix class of transcription factors. Proc. Natl. Acad. Sci. USA, 1997, 94: 5172-5176

[191] Crews ST. Control of cell lineage-specific development and transcription by bHLH-PAS proteins. Genes Dev., 1998, 12: 607-620

[192] Lee Yet al.. Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. J. Cell Sci., 2010, 123: 3547-3557

[193] Li Jet al.. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy. Bioorg. Med. Chem., 2019, 27: 1145-1158

[194] Kewley RJ, Whitelaw ML, Chapman-Smith A. The mammalian basic helix–loop–helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol., 2004, 36: 189-204

[195] Peek CBet al.. Circadian clock interaction with HIF1α mediates oxygenic metabolism and anaerobic glycolysis in skeletal muscle. Cell Metab., 2017, 25: 86-92

[196] Wu Yet al.. Reciprocal regulation between the circadian clock and hypoxia signaling at the genome level in mammals. Cell Metab., 2017, 25: 73-85

[197] Peek CB. Metabolic implications of circadian–HIF crosstalk. Trends Endocrinol. Metab., 2020, 31: 459-468

[198] Suyama Ket al.. Circadian factors BMAL1 and RORα control HIF-1α transcriptional activity in nucleus pulposus cells: implications in maintenance of intervertebral disc health. Oncotarget., 2016, 7: 23056-23071

[199] Ma Zet al.. Deletion of clock gene Bmal1 impaired the chondrocyte function due to disruption of the HIF1α-VEGF signaling pathway. Cell Cycle, 2019, 18: 1473-1489

[200] Yu Cet al.. Hypoxia disrupts the expression levels of circadian rhythm genes in hepatocellular carcinoma. Mol. Med. Rep., 2015, 11: 4002-4008

[201] Ran Jet al.. Hypoxia regulates glycolysis through the HIF-1α/BMAL1/ALDOC axis to reduce oxaliplatin sensitivity in colorectal cancer. J. Cancer, 2025, 16: 2503-2515

[202] Iacobini Cet al.. Mutual regulation between redox and hypoxia-inducible factors in cardiovascular and renal complications of diabetes. Antioxidants, 2022, 11: 2183

[203] Zhang Cet al.. Oxidative stress: a common pathological state in a high-risk population for osteoporosis. Biomed. Pharmacother., 2023, 163: 114834

[204] Samanta D, Semenza GL. Maintenance of redox homeostasis by hypoxia-inducible factors. Redox Biol., 2017, 13: 331-335

[205] Stegen Set al.. HIF-1α promotes glutamine-mediated redox homeostasis and glycogen-dependent bioenergetics to support postimplantation bone cell survival. Cell Metab., 2016, 23: 265-279

[206] Pekovic-Vaughan Vet al.. The circadian clock regulates rhythmic activation of the NRF2/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis. Genes Dev., 2014, 28: 548-560

[207] Mezhnina V, Ebeigbe OP, Poe A, Kondratov RV. Circadian control of mitochondria in reactive oxygen species homeostasis. Antioxid. Redox Signal., 2022, 37: 647-663

[208] Early JOet al.. Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF2. Proc. Natl. Acad. Sci. USA, 2018, 115: E8460-E8468

[209] Kondratov RV, Vykhovanets O, Kondratova AA, Antoch MP. Antioxidant N-acetyl-L-cysteine ameliorates symptoms of premature aging associated with the deficiency of the circadian protein BMAL1. Aging, 2009, 1: 979-987

[210] Stangherlin A, Reddy AB. Regulation of circadian clocks by redox homeostasis. J. Biol. Chem., 2013, 288: 26505-26511

[211] Li Eet al.. BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy. Protein Cell, 2020, 11: 661-679

[212] Alexander RKet al.. Bmal1 integrates mitochondrial metabolism and macrophage activation. eLife, 2020, 9: e54090

[213] Wang Xet al.. Rhodiola crenulata attenuates apoptosis and mitochondrial energy metabolism disorder in rats with hypobaric hypoxia-induced brain injury by regulating the HIF-1α/microRNA 210/ISCU1/2(COX10) signaling pathway. J. Ethnopharmacol., 2019, 241: 111801

[214] Meng X, Wielockx B, Rauner M, Bozec A. Hypoxia-inducible factors regulate osteoclasts in health and disease. Front Cell Dev. Biol., 2021, 9: 658893

[215] Chaikin CAet al.. Control of circadian muscle glucose metabolism through the BMAL1-HIF axis in obesity. Proc. Natl. Acad. Sci. USA, 2025, 122: e2424046122

[216] Luo Wet al.. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell, 2011, 145: 732-744

[217] Dengler VL, Galbraith M, Espinosa JM. Transcriptional regulation by hypoxia inducible factors. Crit. Rev. Biochem. Mol. Biol., 2014, 49: 1-15

[218] Miao Zet al.. Role of Selenoprotein W in participating in the progression of non-alcoholic fatty liver disease. Redox Biol., 2024, 71: 103114

[219] Deng Wet al.. The circadian clock controls immune checkpoint pathway in sepsis. Cell Rep., 2018, 24: 366-378

[220] Timmons GAet al.. The circadian clock protein BMAL1 acts as a metabolic sensor in macrophages to control the production of Pro IL-1β. Front. Immunol., 2021, 12: 700431

[221] Mills E, O’Neill LA. Succinate: a metabolic signal in inflammation. Trends Cell Biol., 2014, 24: 313-320

[222] Mills ELet al.. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell, 2016, 167: 457-470.e13

[223] De Jesus Aet al.. Hexokinase 1 cellular localization regulates the metabolic fate of glucose. Mol. Cell, 2022, 82: 1261-1277.e9

[224] Yao Set al.. Astrocytic lactate dehydrogenase A regulates neuronal excitability and depressive-like behaviors through lactate homeostasis in mice. Nat. Commun., 2023, 14 729

[225] Liu Bet al.. Hypoxia affects HIF-1/LDH-A signaling pathway by methylation modification and transcriptional regulation in Japanese Flounder (Paralichthys olivaceus). Biology, 2022, 11: 1233

[226] Masoud GN, Li W. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharm. Sin. B, 2015, 5: 378-389

[227] Yoo IDet al.. Elevated CLOCK and BMAL1 contribute to the impairment of aerobic glycolysis from astrocytes in Alzheimer’s disease. Int. J. Mol. Sci., 2020, 21: 7862

[228] Biddlestone J, Bandarra D, Rocha S. The role of hypoxia in inflammatory disease (review). Int. J. Mol. Med., 2015, 35: 859-869

[229] Holmquist-Mengelbier Let al.. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell, 2006, 10: 413-423

[230] Zhang FJ, Luo W, Lei GH. Role of HIF-1α and HIF-2α in osteoarthritis. Jt. Bone Spine, 2015, 82: 144-147

[231] Lee SYet al.. Differential but complementary roles of HIF-1α and HIF-2α in the regulation of bone homeostasis. Commun. Biol., 2024, 7: 892

[232] Pelster B, Egg M. Multiplicity of hypoxia-inducible transcription factors and their connection to the circadian clock in the zebrafish. Physiol. Biochem. Zool., 2015, 88: 146-157

[233] Ruan Wet al.. BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury. Nature, 2025, 641: 1017-1028

[234] Ramakrishnan SKet al.. Loss of von Hippel-Lindau protein (VHL) increases systemic cholesterol levels through targeting hypoxia-inducible factor 2α and regulation of bile acid homeostasis. Mol. Cell. Biol., 2014, 34: 1208-1220

[235] Feskanich D, Hankinson SE, Schernhammer ES. Nightshift work and fracture risk: the Nurses’ Health Study. Osteoporos. Int., 2009, 20: 537-542

[236] Quevedo I, Zuniga AM. Low bone mineral density in rotating-shift workers. J. Clin. Densitom., 2010, 13: 467-469

[237] Zhang Het al.. Correlation between occupational hazard exposure and abnormal bone mineral density in steelworkers. BMC Public Health, 2025, 25 1431

[238] Kohl ISet al.. Association between shift work and vitamin D levels in Brazilian female workers. Nutrients, 2025, 17: 1201

[239] Buyukhatipoglu Het al.. Oxidative stress increased in healthcare workers working 24-hour on-call shifts. Am. J. Med. Sci., 2010, 340: 462-467

[240] Zou Yet al.. Nightshift work can induce oxidative DNA damage: a pilot study. BMC Public Health, 2023, 23 891

[241] Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol., 2018, 14: 88-98

[242] Zhang Wet al.. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients. Front. Endocrinol., 2023, 14: 1278505

[243] Sheu A, White CP, Center JR. Bone metabolism in diabetes: a clinician’s guide to understanding the bone-glucose interplay. Diabetologia, 2024, 67: 1493-1506

[244] Javeed N, Matveyenko AV. Circadian etiology of type 2 diabetes mellitus. Physiology, 2018, 33: 138-150

[245] Li Xet al.. Brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 cooperates with glycogen synthase kinase-3β to regulate osteogenesis of bone-marrow mesenchymal stem cells in type 2 diabetes. Mol. Cell. Endocrinol., 2017, 440: 93-105

[246] Liu Tet al.. ED-71 ameliorates bone loss in type 2 diabetes mellitus by enhancing osteogenesis through upregulation of the circadian rhythm coregulator BMAL1. Drug Des. Dev. Ther., 2024, 18: 3903-3919

[247] Catrina SB, Zheng X. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia, 2021, 64: 709-716

[248] March Let al.. Burden of disability due to musculoskeletal (MSK) disorders. Best. Pract. Res. Clin. Rheumatol., 2014, 28: 353-366

[249] Martel-Pelletier Jet al.. Osteoarthritis. Nat. Rev. Dis. Prim., 2016, 2: 16072

[250] Snelling SJBet al.. The chondrocyte-intrinsic circadian clock is disrupted in human osteoarthritis. Chronobiol. Int., 2016, 33: 574-579

[251] Yang Wet al.. Clock gene Bmal1 modulates human cartilage gene expression by crosstalk with Sirt1. Endocrinology, 2016, 157: 3096-3107

[252] Soul Jet al.. Stratification of knee osteoarthritis: two major patient subgroups identified by genome-wide expression analysis of articular cartilage. Ann. Rheum. Dis., 2018, 77: 423

[253] Fisch KMet al.. Identification of transcription factors responsible for dysregulated networks in human osteoarthritis cartilage by global gene expression analysis. Osteoarthr. Cartil., 2018, 26: 1531-1538

[254] Liao Let al.. Deletion of Bmal1 in aggrecan-expressing cells leads to mouse temporomandibular joint osteoarthritis. J. Bone Min. Miner., 2024, 42: 529-537

[255] Dudek Met al.. The chondrocyte clock gene Bmal1 controls cartilage homeostasis and integrity. J. Clin. Invest., 2016, 126: 365-376

[256] Qian Zet al.. Cartilage-specific deficiency of clock gene Bmal1 accelerated articular cartilage degeneration in osteoarthritis by up-regulation of mTORC1 signaling. Int. Immunopharmacol., 2023, 115: 109692

[257] Yudoh Ket al.. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1 alpha in articular chondrocytes: involvement of HIF-1 alpha in the pathogenesis of osteoarthritis. Arthritis Res. Ther., 2005, 7: R904-R914

[258] Pfander D, Cramer T, Schipani E, Johnson RS. HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J. Cell Sci., 2003, 116: 1819-1826

[259] Hu Set al.. Stabilization of HIF-1α alleviates osteoarthritis via enhancing mitophagy. Cell Death Dis., 2020, 11 481

[260] Qing Let al.. Expression of hypoxia-inducible factor-1α in synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis. Exp. Ther. Med., 2017, 13: 63-68

[261] Bouaziz Wet al.. Interaction of HIF1α and β-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice. Proc. Natl. Acad. Sci. USA, 2016, 113: 5453-5458

[262] Zhang Het al.. Maintaining hypoxia environment of subchondral bone alleviates osteoarthritis progression. Sci. Adv., 2023, 9: eabo7868

[263] Leo C, Giaccia AJ, Denko NC. The hypoxic tumor microenvironment and gene expression. Semin. Radiat. Oncol., 2004, 14: 207-214

[264] Wang Cet al.. Stabilization of hypoxia-inducible factor-1α alleviates osteoarthritis via interacting with Per2 and resetting the circadian clock. Tissue Cell, 2022, 79: 101942

[265] Brunette, D. M., Tengvall, P., Textor, M. & Thomsen, P. Properties and Biological Significance of Natural Oxide Films on Titanium and Its Alloys Ch. 7, 171–230 (Springer, Berlin, 2001).

[266] Berglundh T, Abrahamsson I, Lang NP, Lindhe J. De novo alveolar bone formation adjacent to endosseous implants. Clin. Oral. Implants Res., 2003, 14: 251-262

[267] Okawa H, Egusa H, Nishimura I. Implications of the circadian clock in implant dentistry. Dent. Mater. J., 2020, 39: 173-180

[268] Deng S, Qi M, Gong P, Tan Z. The circadian clock component BMAL1 regulates osteogenesis in osseointegration. Front. Pediatr., 2022, 10: 1091296

[269] Nishimura I. Genetic networks in osseointegration. J. Dent. Res, 2013, 92: 109s-18s

[270] Song Set al.. HIF-1α increases the osteogenic capacity of ADSCs by coupling angiogenesis and osteogenesis via the HIF-1α/VEGF/AKT/mTOR signaling pathway. J. Nanobiotechnol., 2023, 21: 257

[271] Wang Yet al.. Impact of high-altitude hypoxia on early osseointegration with bioactive titanium. Front. Physiol., 2021, 12: 689807

[272] Chen Xet al.. Cobalt-doped layered hydroxide coating on titanium implants promotes vascularization and osteogenesis for accelerated fracture healing. Mater. Today Bio, 2024, 24: 100912

[273] Hassan Net al.. Titanium biomaterials with complex surfaces induced aberrant peripheral circadian rhythms in bone marrow mesenchymal stromal cells. PLoS One, 2017, 12: e0183359

[274] Ye Let al.. Circadian rhythm disruption aggravates alveolar bone loss in rat apical periodontitis. Int. Endod. J., 2025, 58: 744-756

[275] Lin Pet al.. A single-cell RNA sequencing guided multienzymatic hydrogel design for self-regenerative repair in diabetic mandibular defects. Adv. Mater., 2024, 36: e2410962

[276] Cao Zet al.. Yes-associated protein promotes bone healing after tooth extraction in mice. Biochem. Biophys. Res. Commun., 2022, 609: 39-47

[277] Dimova EYet al.. The circadian clock protein CRY1 is a negative regulator of HIF-1α. iScience, 2019, 13: 284-304

[278] Vaughan MEet al.. Cryptochromes suppress HIF1α in muscles. iScience, 2020, 23: 101338

[279] Gao L, Mejías R, Echevarría M, López-Barneo J. Induction of the glucose-6-phosphate dehydrogenase gene expression by chronic hypoxia in PC12 cells. FEBS Lett., 2004, 569: 256-260

[280] Peng Let al.. The hepatic clock synergizes with HIF-1α to regulate nucleotide availability during liver damage repair. Nat. Metab., 2025, 7: 148-165

[281] Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab., 2006, 3: 177-185

[282] Beker MCet al.. Interaction of melatonin and Bmal1 in the regulation of PI3K/AKT pathway components and cellular survival. Sci. Rep., 2019, 9 19082

[283] Dyar KAet al.. Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock. Mol. Metab., 2014, 3: 29-41

[284] Bernhardt Set al.. Functional proteomics of breast cancer metabolism identifies GLUL as responder during hypoxic adaptation. J. Proteome Res., 2019, 18: 1352-1362

[285] Lee SH, Golinska M, Griffiths JR. HIF-1-independent mechanisms regulating metabolic adaptation in hypoxic cancer cells. Cells, 2021, 10: 2371

[286] Huang Aet al.. Circadian clock gene expression regulates cancer cell growth through glutaminase. Acta Biochim. Biophys. Sin., 2014, 46: 409-414

[287] Liu Xet al.. Glucose- and glutamine-dependent bioenergetics sensitize bone mechanoresponse after unloading by modulating osteocyte calcium dynamics. J. Clin. Invest, 2023, 133: e164508

[288] Guo Yet al.. Systematic review with meta-analysis: HIF-1α attenuates liver ischemia-reperfusion injury. Transpl. Rev., 2015, 29: 127-134

[289] Feng Jet al.. Downregulation of Bmal1 expression in celiac ganglia protects against hepatic ischemia-reperfusion injury. Biomolecules, 2023, 13: 713

[290] Hwang Set al.. Hypoxia-inducible factor 1α activates insulin-induced gene 2 (Insig-2) transcription for degradation of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase in the liver. J. Biol. Chem., 2017, 292: 9382-9393

[291] Erzurumlu Y, Catakli D, Dogan HK. Circadian oscillation pattern of Endoplasmic Reticulum Quality Control (ERQC) components in human embryonic kidney HEK293 cells. J. Circadian Rhythms, 2023, 21: 1

[292] Ezzeddini Ret al.. Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma. Life Sci., 2019, 224: 169-176

[293] Liu Met al.. Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer. Front. Endocrinol., 2023, 14: 1292011

[294] Hepler Cet al.. Time-restricted feeding mitigates obesity through adipocyte thermogenesis. Science, 2022, 378: 276-284

[295] Jinteng Let al.. BMAL1-TTK-H2Bub1 loop deficiency contributes to impaired BM-MSC-mediated bone formation in senile osteoporosis. Mol. Ther. Nucleic Acids, 2023, 31: 568-585

[296] Min H-Yet al.. Bmal1 induces osteoblast differentiation via regulation of BMP2 expression in MC3T3-E1 cells. Life Sci., 2016, 162: 41-46

[297] Fujihara Y, Kondo H, Noguchi T, Togari A. Glucocorticoids mediate circadian timing in peripheral osteoclasts resulting in the circadian expression rhythm of osteoclast-related genes. Bone, 2014, 61: 1-9

[298] Harfmann BDet al.. Muscle-specific loss of Bmal1 leads to disrupted tissue glucose metabolism and systemic glucose homeostasis. Skelet. Muscle, 2016, 6 12

[299] Chen Met al.. Reprogramming of rhythmic liver metabolism by intestinal clock. J. Hepatol., 2023, 79: 741-757

[300] Gu Wet al.. Metabolic Profile and Lipid Metabolism Phenotype in Mice with Conditional Deletion of Hepatic BMAL1. Int. J. Mol. Sci., 2024, 25: 6070

[301] Bignon Yet al.. Multiomics reveals multilevel control of renal and systemic metabolism by the renal tubular. J. Clin. Invest., 2023, 133: e167133

Funding

National Natural Science Foundation of China (National Science Foundation of China)(No. 82171002)

RIGHTS & PERMISSIONS

The Author(s)